Cargando…
Significance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study
BACKGROUND: The PI3K-AKT pathway is frequently activated in breast cancer. PIK3CA mutations are most frequently found in the helical (exon 9) and kinase (exon 20) domains of this protein. The aim of the present study was to examine the role of different types of PIK3CA mutations in combination with...
Autores principales: | Papaxoinis, George, Kotoula, Vassiliki, Alexopoulou, Zoi, Kalogeras, Konstantine T., Zagouri, Flora, Timotheadou, Eleni, Gogas, Helen, Pentheroudakis, George, Christodoulou, Christos, Koutras, Angelos, Bafaloukos, Dimitrios, Aravantinos, Gerasimos, Papakostas, Pavlos, Charalambous, Elpida, Papadopoulou, Kyriaki, Varthalitis, Ioannis, Efstratiou, Ioannis, Zaramboukas, Thomas, Patsea, Helen, Scopa, Chrisoula D., Skondra, Maria, Kosmidis, Paris, Pectasides, Dimitrios, Fountzilas, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599795/ https://www.ncbi.nlm.nih.gov/pubmed/26452060 http://dx.doi.org/10.1371/journal.pone.0140293 |
Ejemplares similares
-
Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study
por: Koutras, Angelos, et al.
Publicado: (2015) -
Prognostic Significance of ESR1 Gene Amplification, mRNA/Protein Expression and Functional Profiles in High-Risk Early Breast Cancer: A Translational Study of the Hellenic Cooperative Oncology Group (HeCOG)
por: Pentheroudakis, George, et al.
Publicado: (2013) -
XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis
por: Pectasides, Dimitrios, et al.
Publicado: (2012) -
Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial
por: Goussia, Anna, et al.
Publicado: (2018) -
Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials
por: Kotoula, Vassiliki, et al.
Publicado: (2015)